Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Multiple sclerosis

Long-Term Adherence to IFN Beta-1a Treatment when Using RebiSmart® Device in Patients with Relapsing-Remitting Multiple Sclerosis

O. Fernández, R. Arroyo, [ ... ], RELOAD Study Group

The Relationship between Gray Matter Quantitative MRI and Disability in Secondary Progressive Multiple Sclerosis

René-Maxime Gracien, Alina Jurcoane, [ ... ], Johannes C. Klein

Inhibition of Vascular Endothelial Growth Factor Receptor 2 Exacerbates Loss of Lower Motor Neurons and Axons during Experimental Autoimmune Encephalomyelitis

Milos Stanojlovic, Xiaosha Pang, [ ... ], Wensheng Lin

High-Resolution Diffusion Tensor Spinal Cord MRI Measures as Biomarkers of Disability Progression in a Rodent Model of Progressive Multiple Sclerosis

Francesca Gilli, Xi Chen, Andrew R. Pachner, Barjor Gimi

Differential Frequency of CD8+ T Cell Subsets in Multiple Sclerosis Patients with Various Clinical Patterns

Zahra Salehi, Rozita Doosti, [ ... ], Maryam Izad

Efficacy and Safety of OnabotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Tao Cheng, Wei-bing Shuang, [ ... ], Shuo Li

Progressive Dwindling in Multiple Sclerosis: An Opportunity to Improve Care

Jessica E. Martin, Joel Raffel, Richard Nicholas

Increased THEMIS First Exon Usage in CD4+ T-Cells Is Associated with a Genotype that Is Protective against Multiple Sclerosis

Jessica L. Davies, Sara Thompson, [ ... ], Joanne Jones

How Do People with Multiple Sclerosis Experience Prognostic Uncertainty and Prognosis Communication? A Qualitative Study

Laura Dennison, Ellen McCloy Smith, Katherine Bradbury, Ian Galea

The Influence of Differentially Expressed Tissue-Type Plasminogen Activator in Experimental Autoimmune Encephalomyelitis: Implications for Multiple Sclerosis

Lisa CM Dahl, Zeyad Nasa, [ ... ], Robert L. Medcalf

Cost of Illness of Multiple Sclerosis - A Systematic Review

Olivia Ernstsson, Hanna Gyllensten, [ ... ], Anders Norlund

The Cost of Relapsing-Remitting Multiple Sclerosis Patients Who Develop Neutralizing Antibodies during Interferon Beta Therapy

Damiano Paolicelli, Sergio Iannazzo, [ ... ], Maria Trojano

Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational Study

Gabriel Bsteh, Rainer Ehling, [ ... ], Thomas Berger

Advertisement

Create a weekly email alert for: Multiple sclerosis

You can change these options by clicking profile then "Alerts and Notifications"